IGEN International Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IGEN International

IGEN 0.0001000

0.0%

Mar 7 3:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: John Zwiener who started this subject	1/7/2002 8:04:04 AM
From: sim1	Read Replies (1) of 1025

A snippet from this morning's Washington Post ...Igen International Inc., the only biotech company in this year's top 10 stocks, is a special case. Its stock is up primarily because investors are betting on the company to win big in a long legal dispute with Roche Holdings AG, the big European drug company. One case was settled when Roche dropped a lawsuit against Igen and agreed to pay all the legal bills. A jury in federal court in Greenbelt is now hearing a second case, in which Igen claims that Roche cheated it out of licensing fees for medical tests. In closing arguments Friday, Igen's lawyers said the firm is entitled to $710 million in actual damages and billions more in punitive damages because of what they said was deliberate wrongdoing by the Swiss drug company. Even $700 million would be a massive windfall for a company as small as Igen, whose total market value is still only about $800 million after last year's 225 percent gain. Igen's lawsuits and the fear of biological warfare kept last year from being a total bust for biotech investors.... washingtonpost.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next